Amplatzer TorqVue LP Delivery System; Amplatzer TorqVue LP Catheter— 510(k) K261825

Name: FDA 510(k) clearance K261825
Creator: U.S. Food and Drug Administration
Published: 2026-07-02

Substantially Equivalent

Abbott

FDA 510(k) clearance K261825 for Amplatzer TorqVue LP Delivery System; Amplatzer TorqVue LP Catheter, Substantially Equivalent on 2026-07-02. Applicant: Abbott. Device class: 2.

Clearance details

Applicant: Abbott
Product code: Code DQY
Device class: Class 2
Regulation: 21 CFR 870.1250
Advisory panel: Cardiovascular
Date received: 2026-06-02
Decision date: 2026-07-02
Decision: Substantially Equivalent
Clearance type: Special
Location: Saint Paul, MN, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DQY

view all

K260559 — NHanceIT2026-08-14
K262392 — APRO 35 Swift Catheter2026-08-12
K261766 — CPS Locator 3D Plus Delivery Catheter2026-07-29
K262240 — SSPC NXT Delivery Catheter2026-07-29
K261631 — Amplatzer TorqVue Exchange System2026-06-17

More clearances from Abbott

view all

K260993 — Amplatzer TorqVue Delivery System2026-04-24
K251221 — Assert-IQ (DM5000); Assert-IQ (DM5300); Assert-IQ (DM5500); Merlin.net (MN7000)2025-09-17
K233655 — Lingo Glucose System2024-05-29
K222297 — CentriMag Pre-connected Pack2022-12-01
K221213 — EnSite X EP System2022-08-18

Adverse events under product code DQY

product code DQY

Death: 464
Injury: 4,489
Malfunction: 13,721
Other: 2
Total: 18,676

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.